Research progress of moyamoya disease combined with renovascular hypertension
Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder. MMD has been found all over the world, especially in Japan, Korea, and China. In recent years, many r...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.969090/full |
| _version_ | 1817997892820926464 |
|---|---|
| author | Erheng Liu Erheng Liu Heng Zhao Chengyuan Liu Chengyuan Liu Xueyi Tan Xueyi Tan Chao Luo Chao Luo Shuaifeng Yang |
| author_facet | Erheng Liu Erheng Liu Heng Zhao Chengyuan Liu Chengyuan Liu Xueyi Tan Xueyi Tan Chao Luo Chao Luo Shuaifeng Yang |
| author_sort | Erheng Liu |
| collection | DOAJ |
| description | Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder. MMD has been found all over the world, especially in Japan, Korea, and China. In recent years, many reports pointed out that the changes of vascular stenosis in patients with moyamoya disease occurred not only in intracranial vessels, but also in extracranial vessels, especially the changes of renal artery. Renovascular hypertension (RVH) is considered to be one of the important causes of hypertension in patients with moyamoya disease. The pathogenesis of moyamoya disease combined with renovascular hypertension is still unclear, and the selection of treatment has not yet reached a consensus. This article reviews the latest research progress in epidemiology, RNF213 gene, pathomorphology, clinical characteristics and treatment of moyamoya disease combined with renovascular hypertension, in order to provide reference for clinical workers. |
| first_indexed | 2024-04-14T02:45:02Z |
| format | Article |
| id | doaj.art-cb30850e7f764f53beeb4abf8a2066d8 |
| institution | Directory Open Access Journal |
| issn | 2296-875X |
| language | English |
| last_indexed | 2024-04-14T02:45:02Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Surgery |
| spelling | doaj.art-cb30850e7f764f53beeb4abf8a2066d82022-12-22T02:16:37ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2022-08-01910.3389/fsurg.2022.969090969090Research progress of moyamoya disease combined with renovascular hypertensionErheng Liu0Erheng Liu1Heng Zhao2Chengyuan Liu3Chengyuan Liu4Xueyi Tan5Xueyi Tan6Chao Luo7Chao Luo8Shuaifeng Yang9Department of Neurosurgery, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaDepartment of Neurosurgery, The First People's Hospital of Yunnan Province, Kunming, ChinaMoyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder. MMD has been found all over the world, especially in Japan, Korea, and China. In recent years, many reports pointed out that the changes of vascular stenosis in patients with moyamoya disease occurred not only in intracranial vessels, but also in extracranial vessels, especially the changes of renal artery. Renovascular hypertension (RVH) is considered to be one of the important causes of hypertension in patients with moyamoya disease. The pathogenesis of moyamoya disease combined with renovascular hypertension is still unclear, and the selection of treatment has not yet reached a consensus. This article reviews the latest research progress in epidemiology, RNF213 gene, pathomorphology, clinical characteristics and treatment of moyamoya disease combined with renovascular hypertension, in order to provide reference for clinical workers.https://www.frontiersin.org/articles/10.3389/fsurg.2022.969090/fullmoyamoya disease (MMD)renovascular hypertensionRNF213 genechildrenrenal artery stenosis (RAS) |
| spellingShingle | Erheng Liu Erheng Liu Heng Zhao Chengyuan Liu Chengyuan Liu Xueyi Tan Xueyi Tan Chao Luo Chao Luo Shuaifeng Yang Research progress of moyamoya disease combined with renovascular hypertension Frontiers in Surgery moyamoya disease (MMD) renovascular hypertension RNF213 gene children renal artery stenosis (RAS) |
| title | Research progress of moyamoya disease combined with renovascular hypertension |
| title_full | Research progress of moyamoya disease combined with renovascular hypertension |
| title_fullStr | Research progress of moyamoya disease combined with renovascular hypertension |
| title_full_unstemmed | Research progress of moyamoya disease combined with renovascular hypertension |
| title_short | Research progress of moyamoya disease combined with renovascular hypertension |
| title_sort | research progress of moyamoya disease combined with renovascular hypertension |
| topic | moyamoya disease (MMD) renovascular hypertension RNF213 gene children renal artery stenosis (RAS) |
| url | https://www.frontiersin.org/articles/10.3389/fsurg.2022.969090/full |
| work_keys_str_mv | AT erhengliu researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT erhengliu researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT hengzhao researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT chengyuanliu researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT chengyuanliu researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT xueyitan researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT xueyitan researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT chaoluo researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT chaoluo researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension AT shuaifengyang researchprogressofmoyamoyadiseasecombinedwithrenovascularhypertension |